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adjusting for type of operation, body mass index, chronic
renal dysfunction and presence of chronic lung disease.
Conclusions: In contrast to other surgical sites, local
vancomycin administration did not improve the rate of
short term inguinal wound complications following vascu-
lar procedures. A prospective study is needed to further
delineate the role of local vancomycin adjunct treatment on
inguinal wound outcomes.
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Objectives: The purpose of this study is to compare
types of anesthesia in major lower extremity amputations
(LEA) in order to determine whether one type is superior
to another in terms of morbidity and mortality.
Methods: Major LEAs performed between 2005 and
2008 were identified from the American College of Sur-
geons National Surgical Quality Improvement Program
database (ACS-NSQIP) using CPT codes. Anesthesia was
defined as general or regional (epidural, spinal or other
regional). Patient-level co-morbidities and characteristics,
as well as intraoperative and postoperative details were
examined. Complications were analyzed individually, and
in aggregate categories. Procedure-specific variables,
length of stay (LOS), and 30-day mortality were examined.
Characteristics and outcomes were described usingmean
SD or count (%) and associations with anesthesia type were
evaluated for statistical significance. Associations between
morbidity andmortality and anesthesia type were examined
using uni- and multivariable logistic and linear regression
techniques.
Results: 1,592 LEAs were identified for analysis. Of
these, general anesthesia was employed in 1294 (81%) of
these cases. Mean patient age was 68 14 years, 61% were
men, and 66% were white. Overall, the 30-day mortality
was 6.5% (104), any type morbidity occurred in 24.1%
(383), while the mean LOS was 5 (3, 7) days. There was no
statistical difference in the type of surgeon performing the
amputations (85% vascular surgeons overall) between the
types of anesthesia. No univariate differences were observed
by anesthesia type in terms of procedural specifics, LOS or
the occurrence of morbidity (individual or aggregate) or
mortality. Multivariate analyses also demonstrated no rela-
tionship between anesthesia type and the occurrence of
overall morbidity or mortality.
Conclusions: In contemporary surgical practice, based
on outcomes of morbidity and mortality, there appears to
be no difference in anesthesia type when major LEAs are
performed.
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Objectives: Femorofemoral crossover bypasses
(FFCB) are used in both patients with unilateral iliac artery
occlusive disease (IAOD) and in patients with aortoilliac
aneurysms (AIA) treated with an aorto-uni-iliac stentgraft.
The purpose of this study is to evaluate the durability and
effectiveness of a femorofemoral crossover bypass for pa-
tients with aneurysmal and stenotic arterial disease.
Methods: All patients treated with FFCB for aneurys-
mal or stenotic arterial disease from 2001 to 2011 in 2
Dutch tertiary vascular referral hospitals were included.
Data were retrospectively reviewed.
Results: Ninety-five patients were included. The AIA
group consisted of 48 patients (median age 78 years, IQR
72-84; 36 men) and the IAOD group consisted of 47
patients (median age 71, IQR 63-77; 35 men). Twenty-six
of 48 patients in the AIA group (54%) were treated for
ruptured aneurysms. In the IAOD group Fontaine classifi-
cation was as follows: II 60%, III 21% and IV 19%. Tradi-
tional cardiovascular risk factors were comparable between
both groups.Median follow-upwas 19months (IQR 1-41)
in the AIA group and 28months (IQR 14-50) in the IAOD
group. Primary patency after 2 years was 90% for the AIA
group and 79% for the IOAD group (P  .3). Secondary
patency rates were respectively 100% and 95% (P  .4).
Overall one-year mortality was in the AIA group 10% for
non-ruptured aneurysms and 54% for ruptured aneurysms
and was in the IAOD group 13%. In 6 AIA patients (13%)
bypass related complications were reported (5 stenoses/
occlusions requiring percutaneous transluminal angioplasty
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